As done at discretion of treating physician. Blood samples for biochemistry (e.g. serum creatinine, serum urea nitrogen, glucose, liver enzymes) and hematology (e.g. hemoglobin level, leukocyte count, Calciferol site platelet count) were taken at admission.Procedural (angiographic) characteristicsResults from coronary angiographies were analyzed by two experienced cardiologists. Left main coronary stenosis was definedPrognosis in ACS Patients by Apoptotic MoleculesTable 1. Characteristics of studied patients regarding their medical history, index event, medication on Nafarelin web admission, and basic laboratory parameterst.mL, p,0.001, serum creatinine: 160.56145.8 mmol/L vs. 87.5628.1 mmol/L, p,0.001), and leukocyte count: 16.6627.3 vs.10.463.7, p,0.001.Combined End-point free end-point (n = 26) (n = 269) Age (yrs.) Male gender BMI DM AF Hypertension Smoking status History of MI Beta blocker ACEI Aspirin Statin STEMI Killip class LV EF Hemoglobin (g/dl) Leukocyte count (*109/l) Thrombocytes (*1012/l) Serum creatinine (mmol/l) Glucose (mmol/l) ALT (mkatl/l) Left main disease CAD severity Complete revascularization Number of stents Length of stents Procedural difficulties 72.6610.8 20 (76.9) 27.864.4 9 (34.6) 3 (11.5) 17 (65.4) 15 (57.7) 9 (34.6) 8 (30.7) 11 (42.3) 11 (42.3) 8 (30.8) 12 (46.2 ) 1.8761.2 40.5612.2 130.9622.6 16.6627.4 228.6679.1 160.56148.8 9.164.1 0.9561.1 5 (19) 2.19+0.94 6 (23) 1.7361.31 30.19+ 26.19 1(4) 66.1613.4 192 (71.4) 29.1620.6 71 (26.4) 31 (11.5) 149 (55.4) 159 (59.1) 58 (21.6) 100 (37.2) 117 (43.5) 95 (35.3) 83 (30.9) 145 (53.9) 1.1360.5 48.9611.3 138.6624.9 10.463.7 224.6657.6 87.5628.1 7.663.5 0.9661.9 15 (6) 1.9160.81 149 (55) 1.3060.58 22.45611.43 12 (4)The correlation between markers of apoptosis and necrosisp value ,0.05 n.s. n.s. n.s. n.s. n.s. n.s. n.s. n.s. n.s. n.s. n.s. n.s. ,0.001 ,0.001 n.s. ,0.001 n.s. ,0.001 n.s. n.s. ,0.05 0.09 0.002 0.002 0.005 n.s.There was an inverse correlation between peak troponin I levels and the concentration of sTRAIL (r = 20.335, p,0.001). The concentration of sTRAIL correlated inversely with the concentration of leukocyte count (r = 20.220, p,0.001), and positively with LV EF (r = 0.315, p,0.001). There was no correlation between the level of BNP with sFas (r = 0.0728, p = 0.29) or sTRAIL (r = 20.126, p = 0.066).Primary endpoint: death and heart failureIn the univariate regression model, the following variables were significantly (or almost significantly, p,0.01 at least) associated with the combined end-point death or hospitalization for heart failure: age, Killip class, a need for mechanical ventilation, ejection fraction of left ventricle (LV EF), peak troponin level, BNP, serum creatinine, serum urea nitrogen, leukocyte count, hemoglobin level, serum glucose, the concentration of Fas and the concentration of TRAIL, severity of coronary artery disease (i.e. number of diseased vessels), left main disease, complete revascularization, number of stents and total length of stents. Exact numbers are shown in Table 2. All these parameters were next tested in a stepwise multiple logistic regression model. In the multivariate analysis, most important significant predictor of the combined end-point was the concentration of TRAIL (OR 0.11 (95 CI 0.03?.45), p = 0.002). Low concentration was associated with poor prognosis of patients. Other significant predictors of combined end-point were serum creatinine (OR 7.7 (95 CI 1.1?4.5, p = 0.041), complete revascularization (OR 0.19 (95 CI 0.05?.78, p = 0.0.As done at discretion of treating physician. Blood samples for biochemistry (e.g. serum creatinine, serum urea nitrogen, glucose, liver enzymes) and hematology (e.g. hemoglobin level, leukocyte count, platelet count) were taken at admission.Procedural (angiographic) characteristicsResults from coronary angiographies were analyzed by two experienced cardiologists. Left main coronary stenosis was definedPrognosis in ACS Patients by Apoptotic MoleculesTable 1. Characteristics of studied patients regarding their medical history, index event, medication on admission, and basic laboratory parameterst.mL, p,0.001, serum creatinine: 160.56145.8 mmol/L vs. 87.5628.1 mmol/L, p,0.001), and leukocyte count: 16.6627.3 vs.10.463.7, p,0.001.Combined End-point free end-point (n = 26) (n = 269) Age (yrs.) Male gender BMI DM AF Hypertension Smoking status History of MI Beta blocker ACEI Aspirin Statin STEMI Killip class LV EF Hemoglobin (g/dl) Leukocyte count (*109/l) Thrombocytes (*1012/l) Serum creatinine (mmol/l) Glucose (mmol/l) ALT (mkatl/l) Left main disease CAD severity Complete revascularization Number of stents Length of stents Procedural difficulties 72.6610.8 20 (76.9) 27.864.4 9 (34.6) 3 (11.5) 17 (65.4) 15 (57.7) 9 (34.6) 8 (30.7) 11 (42.3) 11 (42.3) 8 (30.8) 12 (46.2 ) 1.8761.2 40.5612.2 130.9622.6 16.6627.4 228.6679.1 160.56148.8 9.164.1 0.9561.1 5 (19) 2.19+0.94 6 (23) 1.7361.31 30.19+ 26.19 1(4) 66.1613.4 192 (71.4) 29.1620.6 71 (26.4) 31 (11.5) 149 (55.4) 159 (59.1) 58 (21.6) 100 (37.2) 117 (43.5) 95 (35.3) 83 (30.9) 145 (53.9) 1.1360.5 48.9611.3 138.6624.9 10.463.7 224.6657.6 87.5628.1 7.663.5 0.9661.9 15 (6) 1.9160.81 149 (55) 1.3060.58 22.45611.43 12 (4)The correlation between markers of apoptosis and necrosisp value ,0.05 n.s. n.s. n.s. n.s. n.s. n.s. n.s. n.s. n.s. n.s. n.s. n.s. ,0.001 ,0.001 n.s. ,0.001 n.s. ,0.001 n.s. n.s. ,0.05 0.09 0.002 0.002 0.005 n.s.There was an inverse correlation between peak troponin I levels and the concentration of sTRAIL (r = 20.335, p,0.001). The concentration of sTRAIL correlated inversely with the concentration of leukocyte count (r = 20.220, p,0.001), and positively with LV EF (r = 0.315, p,0.001). There was no correlation between the level of BNP with sFas (r = 0.0728, p = 0.29) or sTRAIL (r = 20.126, p = 0.066).Primary endpoint: death and heart failureIn the univariate regression model, the following variables were significantly (or almost significantly, p,0.01 at least) associated with the combined end-point death or hospitalization for heart failure: age, Killip class, a need for mechanical ventilation, ejection fraction of left ventricle (LV EF), peak troponin level, BNP, serum creatinine, serum urea nitrogen, leukocyte count, hemoglobin level, serum glucose, the concentration of Fas and the concentration of TRAIL, severity of coronary artery disease (i.e. number of diseased vessels), left main disease, complete revascularization, number of stents and total length of stents. Exact numbers are shown in Table 2. All these parameters were next tested in a stepwise multiple logistic regression model. In the multivariate analysis, most important significant predictor of the combined end-point was the concentration of TRAIL (OR 0.11 (95 CI 0.03?.45), p = 0.002). Low concentration was associated with poor prognosis of patients. Other significant predictors of combined end-point were serum creatinine (OR 7.7 (95 CI 1.1?4.5, p = 0.041), complete revascularization (OR 0.19 (95 CI 0.05?.78, p = 0.0.
http://cathepsin-s.com
Cathepsins
